By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Bruker this morning reported that it expects to post $465 million in revenue for the fourth quarter of 2011 and $1.64 billion in revenue for the full year.

The company released the preliminary results in a filing with the US Securities and Exchange Commission ahead of a presentation at the JP Morgan Healthcare Conference in San Francisco later today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.